The present invention relates to novel crystal forms of 4-{[4-({[4-(2,2,2-trifluoroethoxy)-1,2-benzisoxazol-3-yl]oxy}methyl)piperidin- 1-yl]methyl}-tetrahydro-2H-pyran-4-carboxylic acid. More particularly, the invention relates to polymorph forms (Polymorph Form I or Polymorph Form II), and to processes for the preparation of, compositions containing and to uses of, such polymorph forms.本發明係有關4-{[4-({[4-(2,2,2-三氟乙氧基)-1,2-苯並異唑-3-基]氧基}甲基)哌啶-1-基]甲基}-四氫-2H-吡喃-4-羧酸的新穎晶體形式。更加具體而言,本發明係有關多晶型形式(多晶型形式I或多晶型形式II)和製備此等多晶型形式之方法,含有此等多晶型形式之組合物以及此等多晶型形式之用途。由於本案的圖為實驗數據,並非本案的代表圖。故本案無指定代表圖。
